Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H19ClF3N5O |
| Molecular Weight | 449.857 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=O)C1=CC=CC2=C1N=CN=C2N[C@H](CN3CCC3)C4=CC(=C(Cl)C=C4)C(F)(F)F
InChI
InChIKey=HXAUJHZZPCBFPN-QGZVFWFLSA-N
InChI=1S/C21H19ClF3N5O/c22-16-6-5-12(9-15(16)21(23,24)25)17(10-30-7-2-8-30)29-20-14-4-1-3-13(19(26)31)18(14)27-11-28-20/h1,3-6,9,11,17H,2,7-8,10H2,(H2,26,31)(H,27,28,29)/t17-/m1/s1
| Molecular Formula | C21H19ClF3N5O |
| Molecular Weight | 449.857 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P23443 Gene ID: 6198.0 Gene Symbol: RPS6KB1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/27186432 |
1.0 nM [IC50] | ||
Target ID: P31749 Gene ID: 207.0 Gene Symbol: AKT1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/27186432 |
1.0 nM [IC50] | ||
Target ID: Q9Y243 Gene ID: 10000.0 Gene Symbol: AKT3 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/27186432 |
1.0 nM [IC50] |
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
53 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
15 mg single, oral dose: 15 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
279 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
30 mg 1 times / day multiple, oral dose: 30 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
566 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
60 mg 1 times / day multiple, oral dose: 60 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
533 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
75 mg 1 times / day multiple, oral dose: 75 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
831 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
110 mg 1 times / day multiple, oral dose: 110 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
1300 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
160 mg 1 times / day multiple, oral dose: 160 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
1520 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
200 mg 1 times / day multiple, oral dose: 200 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
1920 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
240 mg 1 times / day multiple, oral dose: 240 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
2110 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
320 mg 1 times / day multiple, oral dose: 320 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
2490 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
380 mg 1 times / day multiple, oral dose: 380 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
87.3 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
30 mg single, oral dose: 30 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
177 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
60 mg single, oral dose: 60 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
269 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
75 mg single, oral dose: 75 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
246 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
110 mg single, oral dose: 110 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
543 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
160 mg single, oral dose: 160 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
472 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
200 mg single, oral dose: 200 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
590 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
240 mg single, oral dose: 240 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
802 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
320 mg single, oral dose: 320 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
1320 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
380 mg single, oral dose: 380 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
769.04 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
240 mg single, oral dose: 240 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
934.92 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
240 mg single, oral dose: 240 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FED |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
759 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
15 mg single, oral dose: 15 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
5410 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
30 mg 1 times / day multiple, oral dose: 30 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
10000 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
60 mg 1 times / day multiple, oral dose: 60 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
9440 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
75 mg 1 times / day multiple, oral dose: 75 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
15500 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
110 mg 1 times / day multiple, oral dose: 110 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
23700 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
160 mg 1 times / day multiple, oral dose: 160 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
28400 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
200 mg 1 times / day multiple, oral dose: 200 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
31300 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
240 mg 1 times / day multiple, oral dose: 240 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
39700 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
320 mg 1 times / day multiple, oral dose: 320 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
41400 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
380 mg 1 times / day multiple, oral dose: 380 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
1480 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
30 mg single, oral dose: 30 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
2730 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
60 mg single, oral dose: 60 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
4370 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
75 mg single, oral dose: 75 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
4200 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
110 mg single, oral dose: 110 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
8650 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
160 mg single, oral dose: 160 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
8180 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
200 mg single, oral dose: 200 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
9200 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
240 mg single, oral dose: 240 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
15200 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
320 mg single, oral dose: 320 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
16500 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
380 mg single, oral dose: 380 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
40016.18 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
240 mg single, oral dose: 240 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
38626.33 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
240 mg single, oral dose: 240 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FED |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
30 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
15 mg single, oral dose: 15 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
30 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
30 mg single, oral dose: 30 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
30 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
60 mg single, oral dose: 60 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
30 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
75 mg single, oral dose: 75 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
30 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
110 mg single, oral dose: 110 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
30 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
160 mg single, oral dose: 160 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
30 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
200 mg single, oral dose: 200 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
30 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
240 mg single, oral dose: 240 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
30 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
320 mg single, oral dose: 320 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
30 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
380 mg single, oral dose: 380 mg route of administration: Oral experiment type: SINGLE co-administered: |
M2698 plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
Funbound
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
2.2% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/34407844/ |
unknown, unknown |
M2698 plasma | Homo sapiens population: UNKNOWN age: UNKNOWN sex: UNKNOWN food status: UNKNOWN |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 21:14:48 GMT 2025
by
admin
on
Tue Apr 01 21:14:48 GMT 2025
|
| Record UNII |
0DXG50I4WD
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB15431
Created by
admin on Tue Apr 01 21:14:48 GMT 2025 , Edited by admin on Tue Apr 01 21:14:48 GMT 2025
|
PRIMARY | |||
|
12871
Created by
admin on Tue Apr 01 21:14:48 GMT 2025 , Edited by admin on Tue Apr 01 21:14:48 GMT 2025
|
PRIMARY | |||
|
C112004
Created by
admin on Tue Apr 01 21:14:48 GMT 2025 , Edited by admin on Tue Apr 01 21:14:48 GMT 2025
|
PRIMARY | |||
|
300000049092
Created by
admin on Tue Apr 01 21:14:48 GMT 2025 , Edited by admin on Tue Apr 01 21:14:48 GMT 2025
|
PRIMARY | |||
|
89808643
Created by
admin on Tue Apr 01 21:14:48 GMT 2025 , Edited by admin on Tue Apr 01 21:14:48 GMT 2025
|
PRIMARY | |||
|
1379545-95-5
Created by
admin on Tue Apr 01 21:14:48 GMT 2025 , Edited by admin on Tue Apr 01 21:14:48 GMT 2025
|
PRIMARY | |||
|
0DXG50I4WD
Created by
admin on Tue Apr 01 21:14:48 GMT 2025 , Edited by admin on Tue Apr 01 21:14:48 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET -> INHIBITOR |
COMPETITIVE INHIBITOR
IC50
|
||
|
|
TARGET -> INHIBITOR |
COMPETITIVE INHIBITOR
IC50
|
||
|
TARGET -> INHIBITOR |
COMPETITIVE INHIBITOR OF ATP BINDING
COMPETITIVE INHIBITOR
IC50
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|